The utility of mass spectrometry-based proteomic data for validation of novel alternative splice forms reconstructed from RNA-Seq data: a preliminary assessment.
about
Proteogenomics: concepts, applications and computational strategiesMost highly expressed protein-coding genes have a single dominant isoform.Leveraging the complementary nature of RNA-Seq and shotgun proteomics data.Next Generation Sequencing Data and Proteogenomics.Protein identification using customized protein sequence databases derived from RNA-Seq data.Comparative analysis of different label-free mass spectrometry based protein abundance estimates and their correlation with RNA-Seq gene expression data.An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.Proteogenomics of Gammarus fossarum to document the reproductive system of amphipods.Integrating genomic, transcriptomic, and interactome data to improve Peptide and protein identification in shotgun proteomics.MSProGene: integrative proteogenomics beyond six-frames and single nucleotide polymorphisms.When one and one gives more than two: challenges and opportunities of integrative omicsUsing proteomic analysis to investigate uniconazole-induced phytohormone variation and starch accumulation in duckweed (Landoltia punctata)Comparative proteomics reveals a significant bias toward alternative protein isoforms with conserved structure and function.Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets.Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.Deep proteome coverage based on ribosome profiling aids mass spectrometry-based protein and peptide discovery and provides evidence of alternative translation products and near-cognate translation initiation eventsDiscovery and mass spectrometric analysis of novel splice-junction peptides using RNA-SeqProteogenomics: Integrating Next-Generation Sequencing and Mass Spectrometry to Characterize Human Proteomic VariationDistinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypesDifferential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.Profiling proteoforms: promising follow-up of proteomics for biomarker discovery.Impact of Alternative Splicing on the Human Proteome.Human Proteomic Variation Revealed by Combining RNA-Seq Proteogenomics and Global Post-Translational Modification (G-PTM) Search Strategy.A proteogenomics approach integrating proteomics and ribosome profiling increases the efficiency of protein identification and enables the discovery of alternative translation start sites.Identification of Small Novel Coding Sequences, a Proteogenomics Endeavor.SpliceProt: a protein sequence repository of predicted human splice variants.Computational identification of micro-structural variations and their proteogenomic consequences in cancer.Detection of proteome diversity resulted from alternative splicing is limited by trypsin cleavage specificity.Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.High throughput discovery of protein variants using proteomics informed by transcriptomics.
P2860
Q28649850-98796B19-7F04-4FF5-B5FF-0CC4FB7BB3EBQ30372321-6305645A-6C72-4586-A58B-FB92EDDC392FQ30855943-DEEEEB26-FF5E-409C-BB63-EE0F2476EA2BQ31133823-426F631F-F5C4-41A9-A5B2-68CAA8B044DBQ34079606-414B281A-B905-4800-8E18-DAEF88AC14EEQ34157419-62D7B45C-7793-491B-AD6F-CA78F6948389Q34503941-773D3B1C-C9D1-487B-BBF6-8E0818BB04C7Q34635017-267ACE53-8D15-4069-B243-DD09729DF17AQ35162490-21C9E8DF-BF47-40B9-96E0-E08A0DF2CB54Q35662983-98866132-C41E-4FBB-B728-E9A131CFCCAFQ35683652-AAC0E0B4-F560-4285-9897-521A94376913Q35774950-3C7FD941-3C36-49DD-B322-1DC8758E9C34Q36179867-612F20F3-456F-4029-BA4E-525F3725C4E6Q36347054-C4F2131E-1CF4-4A18-A3FE-3C35191346AAQ36992268-6AB02187-1D49-43D5-8752-0366F0353725Q37001951-35D8BC0A-2EB3-4253-91D7-B5843416ADD1Q37072907-C4E765F7-4D65-4B8F-AAA6-A05C26D6E556Q37190570-8F3DFADD-9094-44FA-B862-7367DAFEA52AQ37619141-52BFB47E-0CA0-44CC-BA42-891F1CF586C8Q38167708-49D5062A-AC99-400D-A461-C26F82B2AB8FQ38179449-9786B2F4-E645-4F15-B1BC-3095B8F5D38DQ38646466-FBB338DC-7A8B-483F-8235-5EC39E5ACF15Q38794889-028C2111-D2D0-4267-8E85-45E40E94765FQ38962884-4609C6E1-3205-49D1-A069-8FF65DE67145Q38968213-95608C9B-9408-411C-9B25-82AD3D9E80B3Q44674468-196F6601-6E4F-401A-B173-0670E2E1380EQ47264953-26474C8F-3765-4FF1-A6A2-B48B7967EFEFQ47313691-1834008F-CB4A-4D10-B3FF-C5DD4E9A0FF1Q47660956-E5B2C348-0B07-4985-A7B5-F7163CE464D1Q55447996-E089BE26-AAAE-46B7-84E8-855023700E9B
P2860
The utility of mass spectrometry-based proteomic data for validation of novel alternative splice forms reconstructed from RNA-Seq data: a preliminary assessment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The utility of mass spectromet ...... ata: a preliminary assessment.
@ast
The utility of mass spectromet ...... ata: a preliminary assessment.
@en
type
label
The utility of mass spectromet ...... ata: a preliminary assessment.
@ast
The utility of mass spectromet ...... ata: a preliminary assessment.
@en
prefLabel
The utility of mass spectromet ...... ata: a preliminary assessment.
@ast
The utility of mass spectromet ...... ata: a preliminary assessment.
@en
P2860
P1433
P1476
The utility of mass spectromet ...... ata: a preliminary assessment.
@en
P2093
P2860
P2888
P356
10.1186/1471-2105-11-S11-S14
P478
11 Suppl 11
P577
2010-12-14T00:00:00Z
P5875
P6179
1004996725